型肝炎研究的进展:新兴见解和未来方向
Elisabetta Degasperi1, Maria Paola Anolli2, Pietro Lampertico2,3
1Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Lombardia, Italy elisabetta.degasperi@policlinico.mi.it.
Sexually transmitted infections
|June 24, 2024
概括
现在可以使用新的治疗方法来治疗型肝炎病毒 (HDV) 感染. 布列维尔提德为慢性HDV提供了一个有前途的选择,改善了严重肝病患者的治疗结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 传染性疾病 传染性疾病
背景情况:
- 肝炎三角病毒 (HDV) 是一种严重的病毒性肝炎形式,需要B型肝炎病毒 (HBV) 进行复制.
- 慢性HDV感染加速肝纤维化,导致肝硬化和肝细胞癌等并发症.
- 目前的治疗选择,主要是干扰素,已经显示出有限的疗效和安全性问题,特别是在晚期疾病中.
研究的目的:
- 审查最近在HDV流行病学,诊断和治疗方面的进展.
- 专注于HBV-HDV进入抑制剂布莱维尔提德 (BLV) 的临床和现实世界的数据.
- 为提供新兴的高强度病毒治疗化合物的概述.
主要方法:
- 对HV的最新更新进行文献综述.
- 对布莱维尔提德 (BLV) 的临床试验和实践研究的分析.
- 在HV治疗管道中检查新的化合物.
主要成果:
- 布列维 (BLV) 在临床和现实环境中显示出有前途的安全性和有效性,包括晚期肝硬化患者.
- 对于BLV的长期治疗持续时间和反应预测因素仍在调查中.
- 用Pegylated 干扰素-α (PegIFNα) 进行组合治疗可能会增强病毒学和临床反应.
- 几种新的HDV治疗药物正在开发或临床试验中.
结论:
- 现在可用于慢性肝炎三角洲病毒感染的有效治疗策略.
- 布列维尔提德在治疗严重的高强度病毒感染方面取得了重大进展.
- 目前正在进行的研究有望进一步改善HVD治疗模式.
相关概念视频
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...


